If you think this medication could be beneficial for you then dont hesitate to contact us or schedule an appointment online today
You are accepting lower bioavailability, inconsistent absorption, no clinical trial validation, and potentially diminished results in exchange for convenience
Start with baseline lab tests before treatment, then retest after 36 months
Additionally, there are tools, such as DIAL2 (DIAbetes Lifetime perspective model) and SCORE2-Diabetes, which could help physicians assess individuals risk factors, including CV risks, among patients with T2D
Whilst these symptoms are most common during initial treatment or dose increases, they often improve over time
Some providers may support low-dose, infrequent use in select patients with documented cannabinoid medical necessity, but this requires informed consent, liver function assessment, and close monitoring